Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts - Wikidata - awgldk - TriplyDB

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts

http://www.wikidata.org/entity/Q28186129

about

Phosphorylation of the human-transforming-growth-factor-beta-binding protein endoglin Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma Biology of renal tumour cancer stem cells applied in medicine MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin Molecular mechanisms of preeclampsia.Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women.A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction.The role of angiogenesis in rheumatoid arthritis: recent developments Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressure Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study Recent insights into the pathophysiology of preeclampsia.Transforming growth factor-beta1 (TGF-beta1): a potential recovery signal in the post-ischemic kidney.SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity.Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians.Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.Endoglin modulates cellular responses to TGF-beta 1.Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia.Novel biochemical pathways of endoglin in vascular cell physiology.Angiogenic factors in preeclampsia and related disorders Pathophysiology of tumor neovascularization.Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants.Endoglin: a critical mediator of cardiovascular health A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection.CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma.The physiological role of endoglin in the cardiovascular system.Aetiology and physiopathology of preeclampsia and related forms.Endoglin for tumor imaging and targeted cancer therapy.The role of endoglin in post-ischemic revascularization.Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera.The effect of amniotic membrane extract on umbilical cord blood mesenchymal stem cell expansion: is there any need to save the amniotic membrane besides the umbilical cord blood?Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.Expression of normal and truncated forms of human endoglin.Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cells.Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells.Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells.

P2860

Q24316465-B577F465-9BDC-4798-A389-3899213AEBC6 Q24679708-C3C6ACC6-2AA2-46F3-8547-C0D6EB4D5092 Q27004622-166F62EB-0D5E-4246-989F-AEA131987686 Q28480929-B114EFF3-E3B1-4698-92DB-A6D45B533158 Q33344105-626C01F5-FBC0-4931-A75F-2ED5664177CF Q33454185-8B913301-2EBE-4C1E-A11A-EBC05BEF1F9E Q33634727-11146067-873A-48B5-BF0C-4A04B846F480 Q33748650-ED0318F4-3229-424B-BD04-C3C47429A008 Q34037890-1D402D03-78A8-49FB-8781-61B8E0202F1E Q34071300-BE7A76ED-C01D-4249-926E-BC0CA20D0056 Q34136521-082D0D8E-6BE4-4BC2-BA2B-E123656F9F26 Q34143652-3DBB9D06-2959-4FBB-B449-BC26B374400D Q34341543-F16541D9-B064-460E-B881-50ECB3A71EAA Q34404445-AA6BC99B-1DC7-481C-A4C7-B6C2DA5716A4 Q34814841-777F40CB-CFC7-45EA-8D83-E30C8A37771E Q35550776-E382AA46-1EC7-4F2A-BF18-759BAA82C7B7 Q35842042-33CB2E86-4E6E-4221-B5B8-78C584CCD866 Q36185056-DEF67BA6-E70C-4DE7-A530-F773199C9CBB Q36236945-0EF76538-4AA3-4BFE-9429-90DB7A168798 Q36287399-B8938F6A-9F91-4961-A616-9EB87B0B5384 Q36381160-4A469D39-4572-41E4-AFB4-4D3CD1E2D03E Q36526596-DB7B133C-FBE0-4854-AB21-9D1AD88F7FBC Q36742274-FCE26507-DDA0-4495-8B05-4D0F3BFE1273 Q36756322-D78BAEEF-A1CD-4230-8D17-7B2250EC8278 Q36825271-FDBF00CD-3F0D-49A6-88BB-64E43358C4F3 Q36984261-66B7D30A-B780-44C4-8C9C-41237B78C27E Q37133815-1CAB31A3-47D6-4D64-BBE9-B7BD1299E29C Q37362662-CA7247A4-8ABA-4733-A31C-73EA5B9AEA76 Q37764089-C053F6DD-2E41-4BE1-85FB-620BB7204CD3 Q37775427-7448BCAD-7E23-4946-AFA3-06C314F5D29C Q37800883-8DB81F32-A887-4303-91CC-730350103EBD Q38074721-9DCEF83C-4F5A-4BF1-8DE4-52D428DFC26F Q39036151-0156CE62-C719-47E6-83BD-00C186F0139B Q39450324-4B0C54F7-685C-494C-B835-F1386FDAF32D Q39939439-E8361BA1-CA3A-4DB8-90F2-99A6C18BC271 Q40251249-056BB439-8FFF-42A0-84F3-C14C1C89503C Q40958788-D1E75FB8-5348-49DE-93D0-316B58804B50 Q41042158-C36E26DF-7438-4282-8D39-572DE29A1BB9 Q42496992-DFB5856C-39EB-4547-B331-F03E2423DD13 Q43235423-95AC8CA7-A7F6-4EBA-8B67-EF5072EC93BC

P2860

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts

http://www.wikidata.org/entity/Q28186129

description

1992 nî lūn-bûn

@nan

1992 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@ast

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@en

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@nl

type

label

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@ast

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@en

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@nl

prefLabel

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@ast

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@en

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@nl

P1433

Q28186129-B09997EB-08DA-4FF6-836C-AAD08AF3608E

P1476

Q28186129-7C91E6A1-1B11-42CA-8E24-57CDEA277827

P2093

Q28186129-05462AE6-0EC9-4C13-8E70-C02FF2D89DFD

Q28186129-10DC4E54-D769-431B-A8EF-C6193EC2B578

Q28186129-3B1DE23D-D058-4B18-8138-4384E460CE3D

Q28186129-475C2CB6-F29E-4CBF-ABBC-6AFDD65C8402

Q28186129-665F90A4-E6F9-4327-AEFB-645EA5477E85

Q28186129-8BEA593B-F0EE-4E8A-85F8-EBEAD4AA83C3

Q28186129-A6900713-4FE2-488B-9923-CF2182197ACD

Q28186129-B5907935-1377-400D-93CD-BFAB66C3E265

Q28186129-E30D7173-8A80-4A70-8815-912DF0D42DDC

P304

Q28186129-4C49D64F-0880-49A6-A8FA-F13043BFBC89

P31

Q28186129-417E2A8D-428C-49A5-92D4-C44D5FD565B5

P356

Q28186129-C00A959C-80FC-4199-B4FE-2C1A6565BE11

P407

Q28186129-E0CEF4EE-D2CB-4D68-99E7-884183649C24

P433

Q28186129-0EDD0D1C-723B-4754-8597-34E05F79E40E

P478

Q28186129-F1871FAC-1CF2-45D7-BE34-3905EF16D77E

P577

Q28186129-30E6BA5C-8C17-4598-ADA3-D40DBC5ED147

P698

Q28186129-9BFE1BF1-4E75-4466-9B49-0728587CF004

P921

Q28186129-3C6776D2-631B-4A41-94D5-6C893B43AA55

Q28186129-528AFCEB-115F-4D85-9B44-A338EB37ECC2

Q28186129-B21F6A43-754E-4ECD-99A5-C275D8CAA9EC

P356

P1433

International Immunology

P1476

Identification of distinct epi ...... ells, and syncytiotrophoblasts

@en

P2093

A Gougos

http://www.w3.org/2001/XMLSchema#string

A Greaves

http://www.w3.org/2001/XMLSchema#string

A J d'Apice

http://www.w3.org/2001/XMLSchema#string

C Bernabeu

http://www.w3.org/2001/XMLSchema#string

H J Bühring

http://www.w3.org/2001/XMLSchema#string

J A van Mourik

http://www.w3.org/2001/XMLSchema#string

M Letarte

http://www.w3.org/2001/XMLSchema#string

P J O'Connell

http://www.w3.org/2001/XMLSchema#string

S St Jacques

http://www.w3.org/2001/XMLSchema#string

P304

83-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INTIMM/4.1.83

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

1992-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1371694

http://www.w3.org/2001/XMLSchema#string

P921

Syncytiotrophoblast